AzTrials
AzTrials

Acute Coronary SyndromeCOURSENCT03129659

Coronary CT Angiography for Improved Assessment of Suspected Acute Coronary Syndrome

A study testing Coronary CT Angiography in people with Acute Coronary Syndrome and Chest Pain, run by Erasmus Medical Center at 2 sites in Netherlands.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Current evaluation of patients suspected of non-ST-elevation acute coronary syndrome is greatly dictated by the results of high-sensitivity troponins. In a substantial number of patients this approach does not provide a conclusive work-up. Read more about this study

Who is it for?
Ages 30 to 75 years
Conditions the study is for
Acute Coronary Syndrome, Chest Pain
What is being tested?
Coronary CT Angiography
Could I receive a placebo?
No, everyone receives an active treatment
How many people
230 participants
Where
2 sitesNetherlands
Study dates
1 Feb 2018to 1 Sep 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients presenting to the emergency department with symptoms suggestive of NSTE-ACS. They do not fulfil criteria for either "rule-in" or "rule-out" NSTE-ACS based on serial sampling of high-sensitivity troponins and standard clinical work-up.

Who cannot join

  • Inability or unwillingness to provide informed consent.
  • History of proven CAD, defined as documented prior myocardial infarction, percutaneous coronary intervention or coronary artery bypass graft surgery.
  • Previous examination with either invasive angiography or CCTA in the last 3 years.
  • Clinical instability: clinical heart failure, hemodynamic instability, severe chest pain.
  • CCTA-specific contra-indications:
  • Allergy to iodine contrast media
Show all 11Show fewer
  • Pregnancy
  • Impaired renal function: estimated glomerular filtering rate <60% of the age-corrected normal values
  • Severe arrhythmia likely to affect image interpretation
  • BMI > 40
  • Inability to cooperate during the examination.

Trial locations and contacts

2 sites in 1 country.

Admir Dedic, PhD contact

+31107034994

a.dedic@erasmusmc.nl

Netherlands2 sites, 2 recruiting
  • Amphia ziekenhuis

    Breda, North Brabant

    Jeroen Schaap, MD, PhD

    Recruiting
  • Erasmus MC

    Rotterdam, South Holland, 3015 CE

    Admir Dedic, MD,PhD, 0107040704, a.dedic@erasmusmc.nl

    Recruiting

Other trials in Netherlands

About this study

Official title: Coronary CT Angiography for Improved Assessment of Suspected Acute Coronary Syndrome With Inconclusive Diagnostic Work-up

Current evaluation of patients suspected of non-ST-elevation acute coronary syndrome is greatly dictated by the results of high-sensitivity troponins. In a substantial number of patients this approach does not provide a conclusive work-up. Patients typically present with slightly elevated high-sensitivity troponins without significant changes during serial sampling and no other clinical clues that can aid in determining the etiology of their chest pain complaints. Uncertainty remains about the optimal diagnostic management of these patients and they are often admitted to undergo invasive angiography. Coronary CT angiography can improve efficiency of clinical care in these patients by reducing unnecessary hospital admissions and invasive angiography. In this study, the investigators will investigate whether a diagnostic strategy comprising of early coronary CT angiography is more clinically efficient than standard optimal care in patients with an inconclusive work-up for non-ST-elevation acute coronary syndrome.

Being tested
Coronary CT Angiography
Keywords
Coronary CT Angiography, High-sensitivity Troponin, Diagnosis
Medical subject headings
Acute Coronary Syndrome, Chest Pain, Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Coronary CT AngiographyDiagnostic test

    Coronary CT angiography

Study groups in NCT03129659
Study groupRoleWhat they receive
CT-groupExperimentalCoronary CT angiography
Receives: Diagnostic Test: Coronary CT Angiography

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Diagnostic accuracy of coronary CT angiography to identify patients with NSTE-ACS.

    Sensitivity and specificity of coronary CT angiography for the diagnosis of NSTE-ACS.

    Measured: 30 day

Secondary outcomes (2)
  1. Potential improvement of diagnostic accuracy with FFR-CT.

    Off-line calculation of FFR-CT will be performed and the diagnostic accuracy for NSTE-ACS will be determined and compared to conventional coronary CT angiography.

    Measured: 30 day

  2. Clinical characteristics of no obstructive coronary artery disease on CT.

    To determine which clinical characteristics are predictive of not having obstructive coronary artery disease on CT.

    Measured: 30 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Apr 2017
  2. Study start1 Feb 2018
  3. Primary completion1 Sep 2021 (estimated)
  4. Study completion1 Sep 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
230 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03129659
Sponsor's protocol ID
COURSE-11
Acronym
COURSE
Status last verified
Feb 2021
First submitted
16 Apr 2017
Last updated
4 Feb 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Arslan M, Schaap J, van Gorsel B, Aubanell A, Budde RPJ, Hirsch A, Smulders MW, Mihl C, Damman P, Sliwicka O, Habets J, Dubois EA, Dedic A. Coronary computed tomography angiography improves assessment of patients with acute chest pain and inconclusively elevated high-sensitivity troponins. Eur Radiol. 2025 Feb;35(2):789-797. doi: 10.1007/s00330-024-10930-1. Epub 2024 Aug 16.

    PubMed 39150488
  • Arslan M, Schaap J, Van Gorsel B, Budde RP, Bekkers SC, Van Cauteren YJ, Damman P, Habets J, Dubois EA, Dedic A. Coronary CT angiography for improved assessment of patients with acute chest pain and low-range positive high-sensitivity troponins: study protocol for a prospective, observational, multicentre study (COURSE trial). BMJ Open. 2021 Oct 18;11(10):e049349. doi: 10.1136/bmjopen-2021-049349.

    PubMed 34663657

Questions about this trial

What is this clinical trial studying?

A study testing Coronary CT Angiography in people with Acute Coronary Syndrome and Chest Pain, run by Erasmus Medical Center at 2 sites in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 4 Feb 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Admir Dedic, PhD (+31107034994, a.dedic@erasmusmc.nl), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Diagnostic accuracy of coronary CT angiography to identify patients with NSTE-ACS. (time frame: 30 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03129659, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Feb 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in